MY
Maggie Yuen
Director

Maggie Yuen insider trades: AtriCure (ATRC) stock sales

Director, AtriCure Last trade Aug 5, 2026 31 Form 4 filings
$1.1M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2023
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Maggie reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 5, 2026ATRC↓ Sell$134K
Mar 2, 2026PEN↓ Sell$832K
Nov 21, 2025ATRC↓ Sell$107K
Aug 13, 2025PEN↓ Sell$500K
May 2, 2025PEN↓ Sell$598K
Mar 3, 2025PEN↓ Sell$572K
Aug 15, 2024ATRC↓ Sell$84K
May 26, 2023ATRC↓ Sell$203K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ATRC insiders

Open-market trades in the last 12 months

About Maggie Yuen's insider trades

Maggie Yuen is a director at AtriCure (ATRC). Since May 26, 2023, Maggie has reported no open-market purchases and 8 sales worth $3.0M on SEC Form 4. In the last 12 months: 3 sales ($1.1M).

Their filings also include shares withheld for taxes (15 filings), grants and awards (14 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATRC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.